![plant_with_tanks_By_Alexandr_2012_(Own_work)__[CC-BY-SA-3.0_(http_creativecommons.org_licenses_by-sa_3.0)]_via_Wikimedia_Common plant_with_tanks_By_Alexandr_2012_(Own_work)__[CC-BY-SA-3.0_(http_creativecommons.org_licenses_by-sa_3.0)]_via_Wikimedia_Common](../news/img/chemical/plant_with_tanks_By_Alexandr_2012_(Own_work)__[CC-BY-SA-3.0_(http_creativecommons.org_licenses_by-sa_3.0)]_via_Wikimedia_Common.jpg)
Following the big players in the Chemical Manufacturing sector, a number of lesser known corporations are publishing the results. APGR mentioned it has reported operating loss of $-1.214997 millions, for the third quarter of 2022.
The operating loss has deteriorated from $-1.196684 millions, from the third quarter of 2021. But more importantly, the investors are speculating, if the APGRs' will start to show the revenue.
Looking to develop the lucrative revenue streams, corporations occasionally endure some fuzzy stints. One of these, was the financial time-frame ending September 30 2022, where the net loss has extended to $-1.272 millions.
Qsam Biosciences Inc is expected to report next financial earnings on February 23, 2023.